[CHRS] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
08-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -34.76%
YoY- 0.31%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 83,433 37,098 0 0 0 0 0 -
PBT 23,618 -20,004 -62,596 -58,826 -43,685 -44,302 -49,069 -
Tax 51 5,027 70 2,978 6,012 2,541 114 -41.59%
NP 23,567 -20,004 -62,596 -58,808 -43,638 -44,297 -49,067 -
Tax Rate -0.22% - - - - - - -
Total Cost 59,866 57,102 62,596 58,808 43,638 44,297 49,067 14.22%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 28.25 -53.92 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS 0.34 -0.29 -0.92 -0.87 -0.68 -0.74 -0.84 -
EPS Diluted 0.32 -0.29 -0.92 -0.87 -0.68 -0.74 -0.84 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.